Advanced in Disseminated Intravascular Coagulation

Tadaki K. Suzuki

Chiba, JP 
Advanced in Disseminated Intravascular Coagulation
Chiba, JP 
OverviewLocationsClinical Research

Overview

Tadaki Suzuki practices in Chiba, Japan. Suzuki is rated as an Advanced expert by MediFind in the treatment of Disseminated Intravascular Coagulation. Their top areas of expertise are Severe Acute Respiratory Syndrome (SARS), Severe Fever with Thrombocytopenia Syndrome, Progressive Multifocal Leukoencephalopathy, Bone Marrow Aspiration, and Kidney Transplant.

Their clinical research consists of co-authoring 376 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 4 articles in the study of Disseminated Intravascular Coagulation.

Locations

Chiba, 2608670, Japan
Other Locations
Tokyo, Japan
Shinjuku, Japan
Tsuchiura, 3000028, Japan
Musashimurayama, Japan
Japan
Gifu-shi, Japan
Tsurugashima, Japan
Fukushima, 9601295, Japan
Funabashi, Japan
Ebetsu, 0698501, Japan
Setagaya, 1568550, Japan
Tsukuba, 3058573, Japan
Shinjiku, Japan
Okazaki, Japan
Murayama Branch, Murayama, Japan
Ome, Japan
Saitama, 3388570, Japan
Yamagata, Japan
Kawasaki, Japan
Itabashi, 1738610, Japan
R&D Center, Miyoshi, Japan
Fukaya, Japan
Sapporo, Japan
Wako, Japan
Akishima, 1968558, Japan
Nomi, 9231224, Japan
Takamatsu, 7610396, Japan
Asahikawa, Japan
Miemachi, Japan
Moriyama, Japan
Shimotsuke, Japan
Chiyoda, 1018309, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

375 Total Publications

Longitudinal antibody titers measured after COVID-19 mRNA vaccination can identify individuals at risk for subsequent infection.
Longitudinal antibody titers measured after COVID-19 mRNA vaccination can identify individuals at risk for subsequent infection.
Journal: Science translational medicine
Published: September 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Suzuki's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 64 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile